10Apr/14

Heartbleed Bug Hits at Heart of Many Cisco, Juniper Products – Computerworld India

April 10, 2014Heartadmin

Heartbleed Bug Hits at Heart of Many Cisco, Juniper Products
Computerworld India
That’s because Cisco believes it’s a specific feature in OpenSSL that is at the heart of the Heartbleed vulnerability and that it’s not always turned on in products. +More on Network World: Who’s to blame for catastrophic’ Heartbleed Bug? | Cisco …
Deadly ‘Heartbleed’ Virus Arrives in Indian CyberspaceThe New Indian Express

all 2,941 news articles »

10Apr/14

This tailor can cook – Fiji Times

April 10, 2014Liveradmin

This tailor can cook
Fiji Times
Originally from Navsari district, the administrative capital of Gujarat in India, Vinod as he is commonly known, is the owner of Bombay Guji Dhaba located at the Metropole building opposite the Suva market. He specialises in Indian cuisines. “In Fiji …

10Apr/14

Cleveland Arts listings for April 11-17: "Van Gogh Repetitions" at Cleveland … – The Plain Dealer

April 10, 2014Organ Donor, Organs, Other Transplantationadmin

Cleveland Arts listings for April 11-17: “Van Gogh Repetitions” at Cleveland …
The Plain Dealer
Exhibits: “The Accident,” Nicky Nodjoumi, large-scale paintings and ink-on-paper drawings; and “Dinner by Design: Art of the Table,” flatware vessels, dinnerware and other works designed and created by CIA students. Through Monday, May 5. Cleveland …

and more »

10Apr/14

A 'Lesser' Remedy – The Daily Star

April 10, 2014Liveradmin

A ‘Lesser’ Remedy
The Daily Star
Its active ingredient is the extract of the liver and heart of the wild duck and only one bird is needed to make a full year’s global supply of these duck ‘Tic-Tacs’. In 2008, under a government initiative, 2.5 million people were treated with a …

and more »

10Apr/14

Natco seeks to block Gilead's hepatitis C drug patent in India: Report – Economic Times

April 10, 2014Liveradmin

Economic Times

Natco seeks to block Gilead’s hepatitis C drug patent in India: Report
Economic Times
Gilead, whose medicine has been hailed by doctors as a breakthrough in treating the liver-destroying disease, has come under fire over its product’s $1,000 per pill price tag in the United States. India’s patent laws allow a third party to dispute the …

10Apr/14

Emerging Markets Pay 1% of U.S. Price for Gilead Sovaldi – Bloomberg

April 10, 2014Liveradmin

Emerging Markets Pay 1% of U.S. Price for Gilead SovaldiBloombergDeveloping countries such as Egypt, India and Brazil won discounts to pay 1 percent of the $84,000 price Gilead Sciences Inc. (GILD) is charging U.S. patients for its new hepatitis C drug…

10Apr/14

US drug industry group defends price of Gilead hepatitis drug – Chicago Tribune (blog)

April 10, 2014Liveradmin

US drug industry group defends price of Gilead hepatitis drugChicago Tribune (blog)Many people can carry the virus for decades before symptoms appear. But if untreated, it can cause serious liver damage and lead to cirrhosis, liver cancer, the need for…

10Apr/14

US drug industry group defends price of Gilead hepatitis drug – Reuters India

April 10, 2014Liveradmin

US drug industry group defends price of Gilead hepatitis drugReuters IndiaMerck and Bristol-Myers presented new hepatitis C data on Thursday at a major liver disease meeting in London [ID:nL2N0N12E2] [ID:nL2N0N12BT]. Gilead, AbbVie and others will also…

10Apr/14

Pfizer Inc. (NYSE:PFE): Potential New Oncology Therapy – BasicsMedia

April 10, 2014Lungadmin

Pfizer Inc. (NYSE:PFE): Potential New Oncology TherapyBasicsMediaIts other blockbuster drug Viagra is also attracting generic manufacturers and the company recently sued a company, Torrent Pharmaceuticals, based in India. Pfizer Inc. (NYSE:PFE) has rep…

10Apr/14

Natco seeks to block Gilead's hepatitis C drug patent in India: source – Reuters

April 10, 2014Liveradmin

Economic Times

Natco seeks to block Gilead’s hepatitis C drug patent in India: source
Reuters
Gilead, whose medicine has been hailed by doctors as a breakthrough in treating the liver-destroying disease, has come under fire over its product’s $1,000 per pill price tag in the United States. India’s patent laws allow a third party to dispute the …
WHO joins clamour to make new hepatitis C pills affordableDaily News & Analysis
Gilead aims to license hepatitis C drug to 3-4 Indian firmsReuters India
US drug industry group defends price of Gilead hepatitis drugChicago Tribune (blog)
USTrade Voice –Businessweek
all 222 news articles »

Category Archives: Organs